News & Publications

The science, in the open.

Peer-reviewed validation and company milestones as the Gemini platform advances toward the clinic.

Peer-reviewed publications

Validated in the literature.

Nature Communications · 2025

A binary self-amplifying expression platform enabling lipid nanoparticle-free vaccines and nanomedicines

Jefferies, W.A., Choi, K.B., Ribeca, P., et al.
Read the open-access paper →
Frontiers in Pharmacology · 2022

Distinct gene expression patterns of calcium channels and related signaling pathways discovered in lymphomas

Stanwood, S.R., Chong, L.C., Steidl, C., Jefferies, W.A.
Read the article →
Press releases & news

In the news.

11 Jun 2026Eyam Health graduates from the Creative Destruction Lab 15 Jan 2026Eyam and iiDiagnostics launch a UK–Canada collaboration to advance next-generation vaccine development 27 Oct 2025Eyam advances its platform for infectious disease with global-health-funded large-animal studies 21 Jul 2025New research partnership aims to deliver a $1 malaria-prevention shot 18 Jul 2025Eyam marks a milestone in veterinary therapeutics with the Gemini platform 10 Feb 2025Eyam reports interim antibody-therapeutic results and an extension of foundation funding 10 Sep 2024Eyam secures a global-health grant to advance the Gemini expression platform 31 May 2023Eyam establishes an AI research facility in partnership with Mitacs 27 Sep 2022Eyam acquires an option for novel antibody therapeutics in leukemia and lymphoma
From the blog

Insights & perspective.

08 Dec 2025From Proof to Platform: Eyam's Top 10 Milestones of 2025 07 Nov 2025From Vision to Verification: Eyam's Breakout Quarter 02 Jul 2025Gemini: Building the Infrastructure for Global Biologics 14 Mar 2025Ending Malaria for Good: The Role of Gemini-Powered Monoclonal Antibodies 13 Feb 2025Accelerating Innovation in Biologics and Strategic Partnerships 07 Aug 2024Navigating Biotech's Future: AI-Driven Innovations and Market Dynamics